Tirzepatide may help lower blood pressure in adults with obesityTirzepatide significantly lowered the systolic blood for nearly 500 adults with obesity who took the medication for about eight months,...
SURMOUNT-1: Tirzepatide results in 22.5% weight loss in adults with obesity or overweightTirzepatide (5 mg, 10 mg, 15 mg) achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes1 day ago